<b>Changes in the Nijmegen Questionnaire in severe asthma patients treated with dupilumab Cambios en el Cuestionario de Nijmegen en pacientes con asma grave que reciben dupilumab </b>
Incorporating the NQ into the assessment of biologic response in severe asthma may provide additional insights into patient monitoring. Proper management of comorbidities, including HVS, is essential for optimizing asthma outcomes, as uncontrolled comorbidities can confound asthma control.
Institutions
- Hospital Universitario La Paz (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
Publication Details
- Journal
- Revista Alergia México
- Published
- 2025-12-19
- DOI
- https://doi.org/10.29262/ram.v72i4.1478
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00